Syncom Formulations (India) Limited
Syncom Formulations (India) Limited scores highest on Torque (89) and lowest on Earnings (15). Its PosiPenta is 53.63 out of 100, around the middle of similar companies.
On the Penta Grid this week, Syncom Formulations (India) Limited is Grid #61 of 168 in the Healthcare sector in India, and Grid #847 of 2,356 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Syncom Formulations (India) Limited | 53.63 | 63 | 15 | 61 | 89 | 40 |
| Sakar Healthcare Limited | 45.71 | 25 | 69 | 58 | 39 | 37 |
| Sai Parenteral's Limited | 21.40 | 11 | 22 | 22 | 19 | 33 |
| Beta Drugs Limited | 45.47 | 48 | 89 | 27 | 51 | 13 |
| Panacea Biotec Limited | 31.18 | 39 | 6 | 14 | 44 | 53 |
| Indoco Remedies Limited | 39.41 | 40 | 54 | 56 | 6 | 41 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 23.35 |
| P/B ratio | 4.97 |
EEarnings
| Trailing EPS | ₹0.94 |
| Forward EPS | — |
NNitro
| Price | 21.95 |
| 52-week high | 27.49 |
| 52-week low | 10.21 |
| Fall from 52-week high | 20.2% |
TTorque
| Return on equity (ROE) (calculated) | 21.29% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.83 |
| Market cap | ₹2,063 Cr |
| Promoter holding | 50.57% |
| Dividend yield | 0.43% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Syncom Formulations (India) Limited's PosiPenta score?
Syncom Formulations (India) Limited's PosiPenta is 53.63 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Syncom Formulations (India) Limited stand on the Penta Grid?
On the Penta Grid this week, Syncom Formulations (India) Limited is Grid #61 of 168 in the Healthcare sector in India, and Grid #847 of 2,356 in India.
Which PosiPenta pillar is strongest for Syncom Formulations (India) Limited?
Torque (durability), with a score of 89 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Syncom Formulations (India) Limited?
Earnings (growth), with a score of 15 out of 100: much weaker than most similar companies.
Has Syncom Formulations (India) Limited's PosiPenta changed since last week?
Yes, it fell 1.01 points, from 54.64 to 53.63.
PositoAI is for research and education only and is not investment advice.